Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0148081003
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Approved | 02391732 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
Approved | 02391732 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
Marketed | 02392321 | AMGEN CANADA INC | ARANESP | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
Marketed | 02392321 | AMGEN CANADA INC | ARANESP | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
Cancelled Post Market | 02246355 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Schedule D | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
Cancelled Post Market | 02246355 | AMGEN CANADA INC | ARANESP -(HSA-FREE) | Human | Yes | Prescription | 1 | DARBEPOETIN ALFA | 40 MCG / ML |
Application information
Related information
Contact us
Version 4.0.3